Related Experiment Video
Updated: May 7, 2026
11:17
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Pharmacists: an important resource to improve core measure performance.
Carrie S Oliphant1, Jennifer D Twilla
1a Methodist University Hospital , Memphis , Tennessee.
Hospital Topics
|September 17, 2013
Summary
Pharmacists now play a key role in meeting core quality measures, with 50% of these measures related to medications. This study details their contribution and provides an institutional example.
Area of Science:
- Health Services Research
- Pharmacy Practice
- Quality Improvement
Background:
- The Department of Health and Human Services' Quality Initiative (2001) established core measures for patient care.
- Pharmacists were integrated into core measure documentation for medications in November 2007.
- Medication-related measures constitute 50% of the total core measures.
Purpose of the Study:
- To elucidate the pharmacist's role in achieving core quality measures.
- To present a case study of pharmacist utilization in meeting these measures.
Main Methods:
- Review of the Quality Initiative core measures.
- Analysis of medication-related core measures.
- Description of pharmacist's activities and impact at a specific institution.
Main Results:
- A significant portion (50%) of core measures are medication-focused.
- Pharmacists are integral to documenting and improving medication-related care.
- The study institution successfully leverages pharmacists to meet quality targets.
Conclusions:
- Pharmacists are essential for meeting medication-related quality benchmarks.
- Integrating pharmacists into quality improvement initiatives enhances patient care.
- The described model demonstrates effective pharmacist involvement in core measure achievement.
Related Concept Videos
01:20Measurement of Bioavailability: Pharmacodynamic Methods
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
01:30Measurement of Bioavailability: Pharmacokinetic Methods
Pharmacokinetics is a vital branch of pharmacology that examines how drugs are absorbed, distributed, metabolized, and excreted by the body. Two key methodologies in pharmacokinetics are plasma drug concentration studies and urinary drug excretion analyses, both of which provide critical insights into a drug's therapeutic efficacy and bioavailability.Plasma Drug Concentration-Time StudiesPlasma drug concentration-time studies involve analyzing blood samples at specific intervals to quantify...
01:25Errors occurring during blood pressure monitoring
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Several factors...
01:28Biopharmaceutics and Pharmacokinetics: Overview
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the appropriate...
01:27Pharmacodynamic Models: Overview
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...